they sold off over 1/2 of their immune technology and perhaps if they sell off 1/2 needle free technology and keep going into other technology. Bit unlucky with the eye technology it has cost them dearly.
NAL Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held